Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: A [11C]DASB PET imaging study

American Journal of Psychiatry

Volumn 158, Issue 11, 2001, Pages 1843-1849

  Meyer, J H ^a   Wilson, A A ^a   Ginovart, N ^a   Goulding, V ^a   Hussey, D ^a   Hood, K ^a   Houle, S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; CITALOPRAM; PAROXETINE; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG BLOOD LEVEL; DRUG RECEPTOR BINDING; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR OCCUPANCY;

ADULT; BINDING SITES; BIOLOGICAL TRANSPORT; BRAIN; CAUDATE NUCLEUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITALOPRAM; CORPUS STRIATUM; DEPRESSIVE DISORDER, MAJOR; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; PAROXETINE; PREFRONTAL CORTEX; PUTAMEN; REGRESSION ANALYSIS; SEROTONIN UPTAKE INHIBITORS; THALAMUS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035157572     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.158.11.1843     Document Type: Article

References (44)

1. Pharmacological profile of antidepressants and related compounds at human monoamine transporters
2. Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites
3. 11C]McN 5652
4. β-CIT SPECT demonstrates blockade of 5HT-uptake sites by citalopram in the human brain in vivo
5. 123I]-2 β-carbomethoxy-3 β-(4-iodophenyl)tropane and single photon emission computed tomography
6. 123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder
7. 125I]iodophenyl)tropane-2 β-carboxylate in vitro binding to dopamine and serotonin transporters under "physiological" conditions
8. Immunocytochemical localization of the dopamine transporter in human brain
9. 11c]-labelled 2-(phenylthio) araalkylamines
10. 11C](+)McN5652
11. 11C]DASB
12. 11C]DASB binding for in vivo visualization of the serotonin transporter in healthy human volunteers
13. A rating scale for depression
14. The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes
15. An improved method for the measurement of paroxetine in human/serum plasma by HPLC with fluorescence detection
16. 18F] setoperone PET imaging study
17. The Hamilton Rating Scale for depression: A factor analysis
18. 123I]β-CIT SPECT
19. 11C]-iodomethane: A remarkably simple captive solvent method
20. 2 receptors with iodine-123-IBF SPECT
21. 123IBF SPECT in healthy subjects
22. Requirements and implementation of a flexible kinetic modelling tool
23. 3H]paroxetine
24. 3H] paroxetine binding to serotonin uptake sites in human brain tissue
25. 3H]paroxetine binding, a marker of serotonin uptake sites
26. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
27. Modelling of receptor ligand data in PET and SPECT imaging: A review of major approaches
28. 11C]-DASB binding to the serotonin transporter in humans
29. An overlap invariant entropy measure of 3D medical image alignment
30. 2 receptor occupancy of olanzapine in schizophrenia: A PET investigation
31. Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy
32. 2A receptor occupancy in schizophrenic patients
33. Effects of chronic antidepressant treatments on serotonin transporter function, density and mRNA level
34. Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants
35. Desensitization of the neuronal 5-HT carrier following its long-term blockade
36. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: An in vivo microdialysis study
37. Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain
38. 3H]Paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment
39. p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product
40. Multicenter, placebo-controlled fixed-dose study of citalopram in moderate-to-severe depression
41. Low-dose fluoxetine therapy for depression
42. The efficacy and safety of a new enteric-coated formulation of fluoxetine given once weekly during the continuation treatment of major depressive disorder